Cargando…

Impact of the COVID-19 Pandemic on Breast Cancer Management in Portugal: A Cross-Sectional Survey-Based Study of Medical Oncologists

INTRODUCTION: Cancer care providers have faced many challenges in delivering safe care for patients during the COVID-19 pandemic. This cross-sectional survey-based study investigated the impact of the pandemic on clinical practices of Portuguese medical oncologists caring for patients with breast ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Alpuim Costa, Diogo, Nobre, José Guilherme Gonçalves, Fernandes, João Paulo, Batista, Marta Vaz, Simas, Ana, Sales, Carolina, Gouveia, Helena, Ribeiro, Leonor Abreu, Coelho, Andreia, Brito, Margarida, Inácio, Mariana, Cruz, André, Mariano, Mónica, Savva-Bordalo, Joana, Fernandes, Ricardo, Oliveira, André, Chaves, Andreia, Fontes-Sousa, Mário, Sampaio-Alves, Mafalda, Martins-Branco, Diogo, Afonso, Noémia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935098/
https://www.ncbi.nlm.nih.gov/pubmed/35312952
http://dx.doi.org/10.1007/s40487-022-00191-7
_version_ 1784671975589806080
author Alpuim Costa, Diogo
Nobre, José Guilherme Gonçalves
Fernandes, João Paulo
Batista, Marta Vaz
Simas, Ana
Sales, Carolina
Gouveia, Helena
Ribeiro, Leonor Abreu
Coelho, Andreia
Brito, Margarida
Inácio, Mariana
Cruz, André
Mariano, Mónica
Savva-Bordalo, Joana
Fernandes, Ricardo
Oliveira, André
Chaves, Andreia
Fontes-Sousa, Mário
Sampaio-Alves, Mafalda
Martins-Branco, Diogo
Afonso, Noémia
author_facet Alpuim Costa, Diogo
Nobre, José Guilherme Gonçalves
Fernandes, João Paulo
Batista, Marta Vaz
Simas, Ana
Sales, Carolina
Gouveia, Helena
Ribeiro, Leonor Abreu
Coelho, Andreia
Brito, Margarida
Inácio, Mariana
Cruz, André
Mariano, Mónica
Savva-Bordalo, Joana
Fernandes, Ricardo
Oliveira, André
Chaves, Andreia
Fontes-Sousa, Mário
Sampaio-Alves, Mafalda
Martins-Branco, Diogo
Afonso, Noémia
author_sort Alpuim Costa, Diogo
collection PubMed
description INTRODUCTION: Cancer care providers have faced many challenges in delivering safe care for patients during the COVID-19 pandemic. This cross-sectional survey-based study investigated the impact of the pandemic on clinical practices of Portuguese medical oncologists caring for patients with breast cancer. METHODS: An anonymous online survey comprising 42 questions gathered information regarding COVID-19 testing, treatment in (neo)adjuvant and metastatic settings, and other aspects of breast cancer management. Practices before and during the pandemic were compared, and potential differences in outcomes according to respondents’ regions, case volumes, and practice type were explored. RESULTS: Of 129 respondents, 108 worked in the public health system, giving a representative national picture of the impact of the COVID-19 pandemic on breast cancer management. Seventy-one percent of respondents reported a reduction in visits for new cases of breast cancer, and there was a shift towards increased use of telemedicine. Clinical decision-making was largely unaffected in the most aggressive indications (i.e., triple-negative, HER2-positive, visceral crisis). The use of neoadjuvant therapy increased when access to surgery was difficult, whereas dose-dense regimens decreased, and cyclin-dependent kinase 4/6 inhibitor treatment decreased for less aggressive disease and increased for more aggressive disease. The use of oral formulations and metronomic chemotherapy regimens increased, and clinical trial participation decreased. Some differences by respondents’ region and case volume were noted. CONCLUSION: Medical oncologists in Portugal implemented many changes during the COVID-19 pandemic, most of which were logical and reasonable responses to the current healthcare emergency; however, the true impact on patient outcomes remains unknown. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40487-022-00191-7.
format Online
Article
Text
id pubmed-8935098
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-89350982022-03-21 Impact of the COVID-19 Pandemic on Breast Cancer Management in Portugal: A Cross-Sectional Survey-Based Study of Medical Oncologists Alpuim Costa, Diogo Nobre, José Guilherme Gonçalves Fernandes, João Paulo Batista, Marta Vaz Simas, Ana Sales, Carolina Gouveia, Helena Ribeiro, Leonor Abreu Coelho, Andreia Brito, Margarida Inácio, Mariana Cruz, André Mariano, Mónica Savva-Bordalo, Joana Fernandes, Ricardo Oliveira, André Chaves, Andreia Fontes-Sousa, Mário Sampaio-Alves, Mafalda Martins-Branco, Diogo Afonso, Noémia Oncol Ther Original Research INTRODUCTION: Cancer care providers have faced many challenges in delivering safe care for patients during the COVID-19 pandemic. This cross-sectional survey-based study investigated the impact of the pandemic on clinical practices of Portuguese medical oncologists caring for patients with breast cancer. METHODS: An anonymous online survey comprising 42 questions gathered information regarding COVID-19 testing, treatment in (neo)adjuvant and metastatic settings, and other aspects of breast cancer management. Practices before and during the pandemic were compared, and potential differences in outcomes according to respondents’ regions, case volumes, and practice type were explored. RESULTS: Of 129 respondents, 108 worked in the public health system, giving a representative national picture of the impact of the COVID-19 pandemic on breast cancer management. Seventy-one percent of respondents reported a reduction in visits for new cases of breast cancer, and there was a shift towards increased use of telemedicine. Clinical decision-making was largely unaffected in the most aggressive indications (i.e., triple-negative, HER2-positive, visceral crisis). The use of neoadjuvant therapy increased when access to surgery was difficult, whereas dose-dense regimens decreased, and cyclin-dependent kinase 4/6 inhibitor treatment decreased for less aggressive disease and increased for more aggressive disease. The use of oral formulations and metronomic chemotherapy regimens increased, and clinical trial participation decreased. Some differences by respondents’ region and case volume were noted. CONCLUSION: Medical oncologists in Portugal implemented many changes during the COVID-19 pandemic, most of which were logical and reasonable responses to the current healthcare emergency; however, the true impact on patient outcomes remains unknown. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40487-022-00191-7. Springer Healthcare 2022-03-21 /pmc/articles/PMC8935098/ /pubmed/35312952 http://dx.doi.org/10.1007/s40487-022-00191-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research
Alpuim Costa, Diogo
Nobre, José Guilherme Gonçalves
Fernandes, João Paulo
Batista, Marta Vaz
Simas, Ana
Sales, Carolina
Gouveia, Helena
Ribeiro, Leonor Abreu
Coelho, Andreia
Brito, Margarida
Inácio, Mariana
Cruz, André
Mariano, Mónica
Savva-Bordalo, Joana
Fernandes, Ricardo
Oliveira, André
Chaves, Andreia
Fontes-Sousa, Mário
Sampaio-Alves, Mafalda
Martins-Branco, Diogo
Afonso, Noémia
Impact of the COVID-19 Pandemic on Breast Cancer Management in Portugal: A Cross-Sectional Survey-Based Study of Medical Oncologists
title Impact of the COVID-19 Pandemic on Breast Cancer Management in Portugal: A Cross-Sectional Survey-Based Study of Medical Oncologists
title_full Impact of the COVID-19 Pandemic on Breast Cancer Management in Portugal: A Cross-Sectional Survey-Based Study of Medical Oncologists
title_fullStr Impact of the COVID-19 Pandemic on Breast Cancer Management in Portugal: A Cross-Sectional Survey-Based Study of Medical Oncologists
title_full_unstemmed Impact of the COVID-19 Pandemic on Breast Cancer Management in Portugal: A Cross-Sectional Survey-Based Study of Medical Oncologists
title_short Impact of the COVID-19 Pandemic on Breast Cancer Management in Portugal: A Cross-Sectional Survey-Based Study of Medical Oncologists
title_sort impact of the covid-19 pandemic on breast cancer management in portugal: a cross-sectional survey-based study of medical oncologists
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935098/
https://www.ncbi.nlm.nih.gov/pubmed/35312952
http://dx.doi.org/10.1007/s40487-022-00191-7
work_keys_str_mv AT alpuimcostadiogo impactofthecovid19pandemiconbreastcancermanagementinportugalacrosssectionalsurveybasedstudyofmedicaloncologists
AT nobrejoseguilhermegoncalves impactofthecovid19pandemiconbreastcancermanagementinportugalacrosssectionalsurveybasedstudyofmedicaloncologists
AT fernandesjoaopaulo impactofthecovid19pandemiconbreastcancermanagementinportugalacrosssectionalsurveybasedstudyofmedicaloncologists
AT batistamartavaz impactofthecovid19pandemiconbreastcancermanagementinportugalacrosssectionalsurveybasedstudyofmedicaloncologists
AT simasana impactofthecovid19pandemiconbreastcancermanagementinportugalacrosssectionalsurveybasedstudyofmedicaloncologists
AT salescarolina impactofthecovid19pandemiconbreastcancermanagementinportugalacrosssectionalsurveybasedstudyofmedicaloncologists
AT gouveiahelena impactofthecovid19pandemiconbreastcancermanagementinportugalacrosssectionalsurveybasedstudyofmedicaloncologists
AT ribeiroleonorabreu impactofthecovid19pandemiconbreastcancermanagementinportugalacrosssectionalsurveybasedstudyofmedicaloncologists
AT coelhoandreia impactofthecovid19pandemiconbreastcancermanagementinportugalacrosssectionalsurveybasedstudyofmedicaloncologists
AT britomargarida impactofthecovid19pandemiconbreastcancermanagementinportugalacrosssectionalsurveybasedstudyofmedicaloncologists
AT inaciomariana impactofthecovid19pandemiconbreastcancermanagementinportugalacrosssectionalsurveybasedstudyofmedicaloncologists
AT cruzandre impactofthecovid19pandemiconbreastcancermanagementinportugalacrosssectionalsurveybasedstudyofmedicaloncologists
AT marianomonica impactofthecovid19pandemiconbreastcancermanagementinportugalacrosssectionalsurveybasedstudyofmedicaloncologists
AT savvabordalojoana impactofthecovid19pandemiconbreastcancermanagementinportugalacrosssectionalsurveybasedstudyofmedicaloncologists
AT fernandesricardo impactofthecovid19pandemiconbreastcancermanagementinportugalacrosssectionalsurveybasedstudyofmedicaloncologists
AT oliveiraandre impactofthecovid19pandemiconbreastcancermanagementinportugalacrosssectionalsurveybasedstudyofmedicaloncologists
AT chavesandreia impactofthecovid19pandemiconbreastcancermanagementinportugalacrosssectionalsurveybasedstudyofmedicaloncologists
AT fontessousamario impactofthecovid19pandemiconbreastcancermanagementinportugalacrosssectionalsurveybasedstudyofmedicaloncologists
AT sampaioalvesmafalda impactofthecovid19pandemiconbreastcancermanagementinportugalacrosssectionalsurveybasedstudyofmedicaloncologists
AT martinsbrancodiogo impactofthecovid19pandemiconbreastcancermanagementinportugalacrosssectionalsurveybasedstudyofmedicaloncologists
AT afonsonoemia impactofthecovid19pandemiconbreastcancermanagementinportugalacrosssectionalsurveybasedstudyofmedicaloncologists